Stocks battle higher as coronavirus treatment shows promiseA study found Gilead Science's drug remdesivir reduced the risk of death for COVID-19 patients by 62 percent.

A study found Gilead Science's drug remdesivir reduced the risk of death for COVID-19 patients by 62 percent.http://feeds.foxbusiness.com/~r/foxbusiness/latest/~3/Ukyoubb-f6o/us-stocks-july-10-2020
By at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)